Postoperative Pain Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Postoperative Pain pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

The Postoperative Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.


Postoperative Pain Pipeline Insight, 2024 report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market.


Some of the key takeaways from the Postoperative Pain Pipeline Report: 

Companies across the globe are diligently working toward developing novel Postoperative Pain treatment therapies with a considerable amount of success over the years. 

Postoperative Pain companies working in the treatment market are InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others, are developing therapies for the Postoperative Pain treatment 

Emerging Postoperative Pain therapies in the different phases of clinical trials are- INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others are expected to have a significant impact on the Postoperative Pain market in the coming years.  

In August 2023, Arthritis Innovation Corporation (AIC), MedinCell’s collaborator, has completed patient enrollment for the initial of two Phase III trials involving F14 (also known as mdc-CWM), designed to alleviate localized pain following total knee replacement (TKR) surgery. This randomized, multicenter, double-blind study aims to evaluate the safety and effectiveness of a solitary dose of F14 for managing post-operative pain in patients undergoing unilateral TKR.


Postoperative Pain Overview

Postoperative pain refers to the discomfort or soreness experienced by patients following a surgical procedure. It is a common occurrence due to tissue trauma during surgery, and it can vary in intensity depending on factors such as the type of surgery, individual pain tolerance, and the extent of tissue damage. Postoperative pain can manifest at the site of the surgical incision or in nearby areas, and it may be acute or chronic in nature. Effective management of postoperative pain is essential for patient comfort, faster recovery, and overall satisfaction with the surgical experience.


Get a Free Sample PDF Report to know more about Postoperative Pain Pipeline Therapeutic Assessment-


Emerging Postoperative Pain Drugs Under Different Phases of Clinical Development Include:

INSB-200: InSitu Biologics

BB-106: Bexson Biomedical

ATX-201: Allay Therapeutics

ST-2427: SiteOne Therapeutics

LC-400: LipoCure

FX 301: Flexion Therapeutics

NVK-009: Nevakar, Inc.

HR021618: Jiangsu HengRui Medicine Co., Ltd.

CA-008: Concentric Analgesics

OCS-01: Oculis Pharma

HSK21542: Haisco Pharmaceutical Group

VVZ-149: Vivozon Pharmaceutical Inc


Postoperative Pain Route of Administration

Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as 







Postoperative Pain Molecule Type

Postoperative Pain Products have been categorized under various Molecule types, such as

Monoclonal Antibody



Small molecule

Gene therapy 


Postoperative Pain Pipeline Therapeutics Assessment

Postoperative Pain Assessment by Product Type

Postoperative Pain By Stage and Product Type

Postoperative Pain Assessment by Route of Administration

Postoperative Pain By Stage and Route of Administration

Postoperative Pain Assessment by Molecule Type

Postoperative Pain by Stage and Molecule Type


DelveInsight’s Postoperative Pain Report covers around 50+ products under different phases of clinical development like

Late-stage products (Phase III)

Mid-stage products (Phase II)

Early-stage product (Phase I)

Pre-clinical and Discovery stage candidates

Discontinued & Inactive candidates

Route of Administration


Further Postoperative Pain product details are provided in the report. Download the Postoperative Pain pipeline report to learn more about the emerging Postoperative Pain therapies


Some of the key companies in the Postoperative Pain Therapeutics Market include:

Key companies developing therapies for Postoperative Pain are – Pfizer Inc., AbbVie, GlaxoSmithKline plc, Heron Therapeutics, and AFT Pharmaceuticals, and others.


Postoperative Pain Pipeline Analysis:

The Postoperative Pain pipeline report provides insights into 

The report provides detailed insights about companies that are developing therapies for the treatment of Postoperative Pain with aggregate therapies developed by each company for the same.

It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain Treatment.

Postoperative Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

Postoperative Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Postoperative Pain market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.


Download Sample PDF Report to know more about Postoperative Pain drugs and therapies


Postoperative Pain Pipeline Market Drivers

Rise in the number of surgical procedures worldwide, government’s initiative to promote better postoperative pain treatment are some of the important factors that are fueling the Postoperative Pain Market.


Postoperative Pain Pipeline Market Barriers

However, adverse effects associated with the medications, research Gaps in Practice Guidelines for Acute Postoperative Pain Management and other factors are creating obstacles in the Postoperative Pain Market growth.


Scope of Postoperative Pain Pipeline Drug Insight    

Coverage: Global

Key Postoperative Pain Companies: InSitu Biologics, Bexson Biomedical, Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics, Nevakar, Inc., Jiangsu HengRui Medicine Co., Ltd., Concentric Analgesics, Oculis Pharma, Haisco Pharmaceutical Group, Vivozon Pharmaceutical Inc, and others

Key Postoperative Pain Therapies: INSB-200, BB-106, ATX-201, ST-2427, LC-400, FX 301, NVK-009, HR021618, CA-008, OCS-01, HSK21542, VVZ-149, and others

Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies

Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers 


Request for Sample PDF Report for Postoperative Pain Pipeline Assessment and clinical trials


Table of Contents

1. Postoperative Pain Report Introduction

2. Postoperative Pain Executive Summary

3. Postoperative Pain Overview

4. Postoperative Pain- Analytical Perspective In-depth Commercial Assessment

5. Postoperative Pain Pipeline Therapeutics

6. Postoperative Pain Late Stage Products (Phase II/III)

7. Postoperative Pain Mid Stage Products (Phase II)

8. Postoperative Pain Early Stage Products (Phase I)

9. Postoperative Pain Preclinical Stage Products

10. Postoperative Pain Therapeutics Assessment

11. Postoperative Pain Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Postoperative Pain Key Companies

14. Postoperative Pain Key Products

15. Postoperative Pain Unmet Needs

16 . Postoperative Pain Market Drivers and Barriers

17. Postoperative Pain Future Perspectives and Conclusion

18. Postoperative Pain Analyst Views

19. Appendix

20. About DelveInsight


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States

Stay up to date
Register now to get updates on promotions and coupons

Shopping cart